Basic Information
| LncRNA/CircRNA Name | TTN-AS1 |
| Synonyms | NA |
| Region | GRCh38_2:178521183-178779963 |
| Ensemble | ENSG00000237298 |
| Refseq | NR_038272 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qRT-PCR |
| Sample | ovarian cancer tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | TTN-AS1 overexpression inhibits ovarian cancer cell proliferation, colony formation but promotes apoptosis. |
| Pubmed ID | 32049388 |
| Year | 2020 |
| Title | LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer |
External Links
| Links for TTN-AS1 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |